Clinical Trials Logo

Filter by:
NCT ID: NCT05964595 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy

Start date: July 1, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to explore the application of temporal diffusion spectroscopy MRI in head and neck squamous cell carcinoma (HNSCC). The main questions it aims to answer are: - If the quantitative parameters of temporal diffusion spectroscopy MRI can predict the comprehensive positive score (CPS) of pathological PD-L1 expression in HNSCC? - If the quantitative parameters of temporal diffusion spectroscopy MRI can predict the efficacy of neoadjuvant therapy in HNSCC? Participants will receive head and neck MRI, including T2WI, T1WI, diffusion-weighted imaging (DWI), oscillating gradient spin echo (OGSE) and pulsed gradient spin echo (PGSE) sequence before and after neoadjuvant therapy. There is not a comparison group in our study.

NCT ID: NCT05964543 Recruiting - Clinical trials for Gastroesophageal Junction (GEJ) Adenocarcinoma

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Start date: June 21, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The main purpose of this study is to evaluate safety, tolerability and the efficacy of Q-1802 plus SOC compared with SOC. .Pharmacokinetics (PK) ,Pharmacodynamics (PD) of Q-1802 and the immunogenicity profile of Q-1802 will be evaluated as well.

NCT ID: NCT05964101 Recruiting - Neoplasms Clinical Trials

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

GALAXY-1
Start date: October 1, 2023
Phase: Phase 2
Study type: Interventional

This is a single-arm, open, II phase study to evaluate the safety and efficacy of Nivolumab + carboplatin + paclitaxel in 25 newly diagnosed patients with primary tracheal squamous cell carcinoma.

NCT ID: NCT05964049 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

pBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder

Start date: July 16, 2023
Phase: N/A
Study type: Interventional

The investigators aim to evaluate the safety and efficacy of pBFS-guided rTMS therapy targeting DLPFC for patients with treatment-resistant Obsessive-Compulsive Disorder.

NCT ID: NCT05964036 Recruiting - Depression Clinical Trials

pBFS-guided High-dose TMS Over DMPFC for Treatment-resistant Major Depressive Disorder

Start date: July 21, 2023
Phase: N/A
Study type: Interventional

The investigators aim to evaluate the safety and efficacy of pBFS-guided DMPFC target and high-dose rTMS therapy for the treatment of patients with treatment-resistant depression

NCT ID: NCT05964023 Recruiting - Major Depression Clinical Trials

pBFS Guided VS "5-cm Rule" rTMS Over DLPFC for MDD

Start date: August 20, 2023
Phase: N/A
Study type: Interventional

The investigators aim to investigate whether the intervention effect of pBFS-guided rTMS therapy targeting DLPFC is superior to the intervention effect of the traditional "5 cm-rule" guided rTMS therapy in patients with depressive disorders.

NCT ID: NCT05963828 Recruiting - Stroke Clinical Trials

Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network

COMPLIANCE-MT
Start date: August 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of social network in improving drug compliance and risk factors control rate of stroke high-risk population after discharge.

NCT ID: NCT05963737 Recruiting - Clinical trials for Mechanical Ventilation

PMI Guide PS Setting in Pressure Support-ventilated Patients

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Pressure support ventilation (PSV) is an assistant mechanical ventilation mode, that is widely implemented in mechanical ventilation treatment but there are no exact guidelines to guide PS setting. Traditional PS setting strategy (VT/PBW 6-8ml/kg and RR 20-30 breaths/min)has risks of excessive or insufficient assistance. Inspiratory muscle pressure index (PMI) is a noninvasive respiratory mechanical indicator and is available at the bedside. PMI was correlated with inspiratory effort and has the potential ability to predict low inspiratory effort and high inspiratory effort. The primary objective of this study is to investigate the clinical validity of a PMI-guided PS setting strategy. Specifically, the investigators aim to evaluate its impact on inspiratory effort as well as its potential for lung and diaphragm protection. Additionally, the investigators seek to assess the effect of this ventilation strategy on mechanical ventilation outcomes while evaluating the feasibility of our trial protocol.

NCT ID: NCT05963659 Recruiting - Alcohol Dependence Clinical Trials

Nitrate Modulates Cognitive Impairment Via Oral Microbiota.

Start date: September 10, 2023
Phase: N/A
Study type: Interventional

Alcohol use is increasingly prevalent in modern society and is known to cause cognitive impairment and dysregulation of inflammatory responses. In the present study, the investigators want to perform a randomised controlled trials to test whether nitrate could change the oral microbiota and benefit the cognitive impairment in alcohol dependence patients. The investigators survey the oral bacterial communities in saliva samples of 70 alcohol dependent patients following 14 days of dietary inorganic nitrate (nitrate-rich beetroot juice, ~750 mg NO3- /d) and placebo (nitrate-depleted beetroot juice, ~1 mg NO3- /d) supplementation.

NCT ID: NCT05963542 Recruiting - Insomnia Clinical Trials

Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia

Start date: September 7, 2023
Phase: N/A
Study type: Interventional

Considering the lack of evidence on the effects of combining acceptance and commitment therapy (ACT) with customized sound therapy for tinnitus-related insomnia patients, investigators designed this single-blind, 6-months randomized, controlled trial with two parallel groups. One is the ACT + sound therapy group, and the other is the sound therapy group.